Search

Your search keyword '"Bager, Peter"' showing total 203 results
Start Over Author "Bager, Peter"
203 results on '"Bager, Peter"'

1. A standardised protocol for assessment of relative SARS-CoV-2 variant severity, with application to severity risk for COVID-19 cases infected with Omicron BA.1 compared to Delta variants in six European countries

Author

Nyberg, Tommy, Bager, Peter, Svalgaard, Ingrid Bech, Bejko, Dritan, Bundle, Nick, Evans, Josie, Krause, Tyra Grove, McMenamin, Jim, Mossong, Joël, Mutch, Heather, Omokanye, Ajibola, Peralta-Santos, André, Leite, Pedro Pinto, Starrfelt, Jostein, Thelwall, Simon, Veneti, Lamprini, Whittaker, Robert, Wood, John, Pebody, Richard, and Presanis, Anne M

Subjects
Quantitative Biology - Populations and Evolution
Abstract

Several SARS-CoV-2 variants that evolved during the COVID-19 pandemic have appeared to differ in severity, based on analyses of single-country datasets. With decreased SARS-CoV-2 testing and sequencing, international collaborative studies will become increasingly important for timely assessment of the severity of newly emerged variants. The Joint WHO Regional Office for Europe and ECDC Infection Severity Working Group was formed to produce and pilot a standardised study protocol to estimate relative variant case-severity in settings with individual-level SARS-CoV-2 testing and COVID-19 outcome data during periods when two variants were co-circulating. To assess feasibility, the study protocol and its associated statistical analysis code was applied by local investigators in Denmark, England, Luxembourg, Norway, Portugal and Scotland to assess the case-severity of Omicron BA.1 relative to Delta cases. After pooling estimates using meta-analysis methods (random effects estimates), the risk of hospital admission (adjusted hazard ratio [aHR]=0.41, 95% CI 0.31-0.54), ICU admission (aHR=0.12, 95% CI 0.05-0.27), and death (aHR=0.31, 95% CI 0.28-0.35) was lower for Omicron BA.1 compared to Delta cases. The aHRs varied by age group and vaccination status. In conclusion, this study has demonstrated the feasibility of conducting variant severity analyses in a multinational collaborative framework. The results add further evidence for the reduced severity of the Omicron BA.1 variant., Comment: 21 pages, 6 figures (excluding supplementary material)

Published
2023
Full Text
View/download PDF

4. Relative vaccine protection, disease severity, and symptoms associated with the SARS-CoV-2 omicron subvariant BA.2.86 and descendant JN.1 in Denmark: a nationwide observational study

Author

Christiansen, Lasse Engbo, Gubbels, Sophie, Trebbien, Ramona, Westergaard, Casper, Escobar-Herrera, Leandro Andrés, Gunalan, Vithiagaran, Ring, Aleksander, Bennedbæk, Marc, Steenhard, Nina, Mørk Hartmann, Esben, Nielsen, Lene, Terp Andersen, Dorte, Thomsen, Marianne Kragh, Marmolin, Ea Sofie, Vognbjerg Sydenham, Thomas, Hoegh, Silje Vermedal, Pinholt, Mette, Møller, Josefine Tange, Vasehus Madsen, Tina, Fuglsang-Damgaard, David, Jokelainen, Pikka, Krause, Tyra Grove, Ullum, Henrik, Søborg, Bolette, Valentiner-Branth, Palle, Moustsen-Helms, Ida Rask, Bager, Peter, Larsen, Tine Graakjær, Møller, Frederik Trier, Vestergaard, Lasse Skafte, Rasmussen, Morten, and Hansen, Christian Holm

Published
2024
Full Text
View/download PDF

7. Relative vaccine protection, disease severity, and symptoms associated with the SARS-CoV-2 omicron subvariant BA.2.86 and descendant JN.1 in Denmark: a nationwide observational study

Author

Moustsen-Helms, Ida Rask, primary, Bager, Peter, additional, Larsen, Tine Graakjær, additional, Møller, Frederik Trier, additional, Vestergaard, Lasse Skafte, additional, Rasmussen, Morten, additional, Hansen, Christian Holm, additional, Christiansen, Lasse Engbo, additional, Gubbels, Sophie, additional, Trebbien, Ramona, additional, Westergaard, Casper, additional, Escobar-Herrera, Leandro Andrés, additional, Gunalan, Vithiagaran, additional, Ring, Aleksander, additional, Bennedbæk, Marc, additional, Steenhard, Nina, additional, Mørk Hartmann, Esben, additional, Nielsen, Lene, additional, Terp Andersen, Dorte, additional, Thomsen, Marianne Kragh, additional, Marmolin, Ea Sofie, additional, Vognbjerg Sydenham, Thomas, additional, Hoegh, Silje Vermedal, additional, Pinholt, Mette, additional, Møller, Josefine Tange, additional, Vasehus Madsen, Tina, additional, Fuglsang-Damgaard, David, additional, Jokelainen, Pikka, additional, Krause, Tyra Grove, additional, Ullum, Henrik, additional, Søborg, Bolette, additional, and Valentiner-Branth, Palle, additional

Published
2024
Full Text
View/download PDF

9. Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study

Author

Edslev, Sofie Marie, Sieber, Raphael Niklaus, Ingham, Anna Cäcilia, Overvad, Maria, Agermose Gram, Mie, Kristensen Lomholt, Frederikke, Hallundbæk, Louise, Hjorth Espensen, Caroline, Gubbels, Sophie, Karakis, Marianne, Lauenborg Møller, Karina, Schytte Olsen, Stefan, Harboe, Zitta Barrella, Klint Johannesen, Caroline, van Wijhe, Maarten, Holler, Jon Gitz, Dessau, Ram Benny Christian, Barfred Friis, Martin, Fuglsang-Damgaard, David, Pinholt, Mette, Vognbjerg Sydenham, Thomas, Coia, John Eugenio, Marmolin, Ea Sofie, Fomsgaard, Anders, Fonager, Jannik, Rasmussen, Morten, Cohen, Arieh, Bager, Peter, Wohlfahrt, Jan, Bhatt, Samir, Stegger, Marc, Legarth, Rebecca, Møller, Camilla Holten, Skov, Robert Leo, Valentiner-Branth, Palle, Voldstedlund, Marianne, Fischer, Thea K, Simonsen, Lone, Kirkby, Nikolai Søren, Thomsen, Marianne Kragh, Spiess, Katja, Marving, Ellinor, Larsen, Nicolai Balle, Lillebaek, Troels, Ullum, Henrik, Mølbak, Kåre, and Krause, Tyra Grove

Published
2022
Full Text
View/download PDF

10. Postacute symptoms 4 months after SARS-CoV-2 infection during the Omicron period: a nationwide Danish questionnaire study.

Author

Spiliopoulos, Lampros, Sørensen, Anna Irene Vedel, Bager, Peter, Nielsen, Nete Munk, Hansen, Jørgen Vinsløv, Koch, Anders, Meder, Inger Kristine, Videbech, Poul, Ethelberg, Steen, and Hviid, Anders

Subjects
IMMUNIZATION, RESEARCH funding, POST-acute COVID-19 syndrome, QUESTIONNAIRES, TASTE disorders, AGE factors in disease, MEMORY, GENETIC mutation, CONFIDENCE intervals, COVID-19, VACCINATION status, TIME
Abstract

Postacute symptoms are not uncommon after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection with pre-Omicron variants. How the Omicron variant and coronavirus disease 2019 (COVID-19) booster vaccination influence the risk of postacute symptoms is less clear. We analyzed data from a nationwide Danish questionnaire study, EFTER-COVID, comprising 36 109 individuals aged ≥15 years who were tested between July 2021 and January 2022, to evaluate the associations of the Omicron variant and COVID-19 booster vaccination with postacute symptoms and new-onset general health problems 4 months after infection with SARS-CoV-2. Risk differences (RDs) were estimated by comparing Omicron cases with controls, comparing Omicron cases with Delta cases, and comparing Omicron cases vaccinated with 3 doses with those vaccinated with 2 doses, adjusting for age, sex, body mass index, self-reported chronic diseases, Charlson comorbidity index, health-care occupation, and vaccination status. Four months after testing for SARS-CoV-2 during the Omicron period, cases experienced substantial postacute symptoms and new-onset health problems in comparison with controls; the largest RD was observed for memory issues (RD = 7.4%; 95% CI, 6.4-8.3). However, risks were generally lower than those in the Delta period, particularly for dysosmia (RD = –15.0%; 95% CI, −17.0 to −13.2) and dysgeusia (RD = –11.2%; 95% CI, −13.2 to −9.5). Booster vaccination was associated with fewer postacute symptoms and new-onset health problems 4 months after Omicron infection as compared with 2 doses of COVID-19 vaccine. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

12. Comparison of morbidity and mortality after bloodstream infection with vancomycin-resistant versus -susceptible Enterococcus faecium: A nationwide cohort study in Denmark, 2010-2019

Author

Bager, Peter, primary, Kähler, Jonas, additional, Andersson, Mikael, additional, Holzknecht, Barbara Juliane, additional, Kjær Hansen, Sanne Grønvall, additional, Schønning, Kristian, additional, Nielsen, Karen Leth, additional, Koch, Kristoffer, additional, Pinholt, Mette, additional, Voldstedlund, Marianne, additional, Larsen, Anders Rhod, additional, Kristensen, Brian, additional, Mølbak, Kåre, additional, Sönksen, Ute Wolff, additional, Skovgaard, Sissel, additional, Skov, Robert, additional, and Hammerum, Anette M., additional

Published
2024
Full Text
View/download PDF

14. A register and questionnaire study of long-term general health symptoms following SARS-CoV-2 vaccination in Denmark.

Author

O'Regan, Elisabeth, Svalgaard, Ingrid Bech, Sørensen, Anna Irene Vedel, Spiliopoulos, Lampros, Bager, Peter, Nielsen, Nete Munk, Hansen, Jørgen Vinsløv, Koch, Anders, Meder, Inger Kristine, Videbech, Poul, Ethelberg, Steen, and Hviid, Anders

Subjects
VACCINATION, JOINT pain, MALARIA, SLEEP, SARS-CoV-2, FEVER
Abstract

Many individuals who refuse COVID-19 vaccination have concerns about long-term side effects. Here, we report findings on self-reported symptoms from a Danish survey- and register study. The study included 34,868 vaccinated primary course recipients, 95.8% of whom received mRNA vaccines, and 1,568 unvaccinated individuals. Participants had no known history of SARS-CoV-2 infection. Using g-computation on logistic regression, risk differences (RDs) for symptoms between vaccinated and unvaccinated persons were estimated with adjustments for possible confounders. Within six weeks after vaccination, higher risks were observed for physical exhaustion (RD 4.9%, 95% CI 1.1% to 8.4%), fever or chills (RD 4.4%, 95% CI 2.1% to 6.7%), and muscle/joint pain (RD 7.0%, 95% CI 3.1% to 10.7%), compared to unvaccinated individuals. Beyond twenty-six weeks, risks were higher among the vaccinated for sleeping problems (RD 3.0, 95% 0.2 to 5.8), fever or chills (RD 2.0, 95% CI 0.4 to 3.6), reduced/altered taste (RD 1.2, 95% CI 0.2 to 2.3) and shortness of breath (RD 2.6, 95% CI 0.9 to 4.0). However, when examining pre-omicron responses only, the difference for reduced/altered taste was significant. As expected, the risk of experiencing physical exhaustion, fever or chills, and muscle/joint pain was higher among persons who responded within six weeks of completing the primary course. No significant differences were observed for the 7-25-week period after vaccination. Associations for the period beyond 26 weeks must be interpreted with caution and in the context of undetected SARS-CoV-2 infection, wide confidence intervals, and multiple testing. Overall, we observe no concerning signs of long-term self-reported physical, cognitive, or fatigue symptoms after vaccination. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

15. A hybrid register and questionnaire study of Covid-19 and post-acute sick leave in Denmark.

Author

O'Regan, Elisabeth, Svalgaard, Ingrid Bech, Sørensen, Anna Irene Vedel, Spiliopoulos, Lampros, Bager, Peter, Nielsen, Nete Munk, Hansen, Jørgen Vinsløv, Koch, Anders, Ethelberg, Steen, and Hviid, Anders

Subjects
SICK leave, COVID-19, LUNG diseases, LIVING conditions, RISK-taking behavior
Abstract

Post-acute sick leave is an underexplored indicator of the societal burden of SARS-CoV-2. Here, we report findings about self-reported sick leave and risk factors thereof from a hybrid survey and register study, which include 37,482 RT-PCR confirmed SARS-CoV-2 cases and 51,336 test-negative controls who were tested during the index- and alpha-dominant waves. We observe that an additional 33 individuals per 1000 took substantial sick leave following acute infection compared to persons with no known history of infection, where substantial sick leave is defined as >1 month of sick leave within the period 1–9 months after the RT-PCR test date. Being female, 50–65 years, or having certain pre-existing health conditions such as obesity, chronic lung diseases, and fibromyalgia each increase risk for taking substantial sick leave. Altogether, these results may help motivate improved diagnostic and treatment options for persons living with post-Covid conditions. Authors utilise a questionnaire-based approach to survey self-reported, post-acute sick leave and risk factors in cases of SARS-CoV-2. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

16. A standardised protocol for relative SARS-CoV-2 variant severity assessment, applied to Omicron BA.1 and Delta in six European countries, October 2021 to February 2022.

Author

Nyberg, Tommy, Bager, Peter, Svalgaard, Ingrid Bech, Bejko, Dritan, Bundle, Nick, Evans, Josie, Grove Krause, Tyra, McMenamin, Jim, Mossong, Joël, Mutch, Heather, Omokanye, Ajibola, Peralta-Santos, André, Pinto-Leite, Pedro, Starrfelt, Jostein, Thelwall, Simon, Veneti, Lamprini, Whittaker, Robert, Wood, John, Pebody, Richard, and Presanis, Anne M.

Published
2023
Full Text
View/download PDF

19. A Standardised Protocol for Assessment of Relative SARS-CoV-2 Variant Severity, with Application to Severity Risk for COVID-19 Cases Infected with Omicron BA.1 Compared to Delta Variants in six European Countries

Author

Nyberg, Tommy, primary, Bager, Peter, additional, Bech Svalgaard, Ingrid, additional, Bejko, Dritan, additional, Bundle, Nick, additional, Evans, Josie, additional, Grove Krause, Tyra, additional, McMenamin, Jim, additional, Mossong, Joël, additional, Mutch, Heather, additional, Omokanye, Ajibola, additional, Peralta-Santos, André, additional, Leite, Pedro Pinto, additional, Starrfelt, Jostein, additional, Thelwall, Simon, additional, Veneti, Lamprini, additional, Whittaker, Robert, additional, Wood, John, additional, Pebody, Richard, additional, and Presanis, Anne M., additional

Published
2023
Full Text
View/download PDF

20. Clinical progression, disease severity, and mortality among adults hospitalized with COVID-19 caused by the Omicron and Delta SARS-CoV-2 variants:A population-based, matched cohort study

Author

Harboe, Zitta Barrella, Roed, Casper, Holler, Jon Gitz, Khan, Fahim Iqbal, Abdulrahman, Aya Nihad Abdulrahman, Mulverstedt, Stefan Lundby, Lindgaard-Jensen, Betina, Bertelsen, Barbara Bonnesen, Søborg, Christian, Nielsen, Thyge Lynghøj, Hansen, Line Vinum, Madsen, Birgitte Lindegaard, Browatzki, Andrea, Eiberg, Mads, Bernhard, Peter Haahr, Pedersen, Emilie Marie Juelstorp, Egelund, Gertrud Baunbaek, Dungu, Arnold Matovu, Sejdic, Adin, Mathiesen, Inger Hee Mabuza, Jespersen, Naja Z., Petersen, Pelle Trier, Nielsen, Lars, Jepsen, Micha Phill Grønholm, Pedersen, Thomas Ingemann, Eriksson, Robert, Seitz-Rasmussen, Hans Eric Sebastian, Bestle, Morten, Andersen, Henrik, Skram, Ulrik, Skøtt, Mads Rømer, Altaraihi, Sarah, Sivapalan, Pradeesh, Jensen, Jens Ulrik Stæhr, Bagge, Kristian, Jørgensen, Kristina Melbardis, Knudsen, Maja Johanne Søndergaard, Leineweber, Thomas, Schneider, Uffe Vest, Ahlstrom, Magnus Glindvad, Rytter, Sofie, Le Dous, Nina, Ravn, Pernille, Reiter, Nanna, Podlekareva, Daria, Knudsen, Andreas, Johnsen, Stine, Kristensen, Lars Erik, Leding, Cæcilie, Hertz, Bastian Bryan, Benfield, Thomas, Kirk, Ole, Ostrowski, Sisse Rye, Sigurdsson, Sigurdur Thor, Perner, Anders, Kirkby, Nikolai, Pedersen, Martin Schou, Van Wijhe, Maarten, Simonsen, Lone, Bager, Peter Michael, Krause, Tyra Grove, Voldstedlund, Marianne, Christiansen, Lasse Engbo, Stegger, Marc, Cohen, Arieh, Fonager, Jannik, Fomsgaard, Anders, Legarth, Rebecca, Rasmussen, Morten, Gubbels, Sophie, Wohlfahrt, Jan, Lillebæk, Troels, Johannesen, Caroline Klint, and Fischer, Thea K.

Abstract

Background To compare the intrinsic virulence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) omicron variant with the delta variant in hospitalized adults with coronavirus disease 2019 (COVID-19). Methods All adults hospitalized in the Capital Region of Copenhagen with a positive reverse transcription polymerase chain reaction test for SARS-CoV-2 and an available variant determination from 1 September 2021 to 11 February 2022. Data from health registries and patient files were used. Omicron and Delta patients were matched (1:1) by age, sex, comorbidities, and vaccination status. We calculated crude and adjusted hazard ratios (aHRs) for severe hypoxemia and mortality at 30 and 60 days. Results 1,043 patients were included. Patients with Omicron were older, had more comorbidities, were frailer, and more often had three vaccine doses than those with Delta. Fewer patients with Omicron developed severe hypoxemia than those with Delta (aHR, 0.55; 95% confidence interval, 0.38 0.78). Omicron patients exhibited decreased aHR for 30- day mortality compared to Delta (aHR, 0.61; 0.39 0.95). Omicron patients who had received three vaccine doses had lower mortality compared to Delta patients who received three doses (aHR, 0.31;0.16 0.59), but not among those who received two or 0 1 doses (aHR, 0.86; 0.41 1.84 and 0.94; 0.49 1.81 respectively). Similar findings were observed for mortality at 60 days. Similar outcomes were obtained in the analyses of 316 individually matched patients. Conclusions Among adults hospitalized with COVID-19, those with Omicron had less severe hypoxemia and nearly 40% higher 30- and 60-day survival, as compared with those with Delta, mainly driven by a larger proportion of Omicron patients vaccinated with three doses of an mRNA vaccine.

Published
2023

24. Observed protection against SARS-CoV-2 reinfection following a primary infection: A Danish cohort study among unvaccinated using two years of nationwide PCR-test data

Author

Michlmayr, Daniela, primary, Hansen, Christian Holm, additional, Gubbels, Sophie Madeleine, additional, Valentiner-Branth, Palle, additional, Bager, Peter, additional, Obel, Niels, additional, Drewes, Birgitte, additional, Møller, Camilla Holten, additional, Møller, Frederik Trier, additional, Legarth, Rebecca, additional, Mølbak, Kåre, additional, and Ethelberg, Steen, additional

Published
2022
Full Text
View/download PDF

25. Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study

Author

Bager, Peter, primary, Wohlfahrt, Jan, additional, Bhatt, Samir, additional, Stegger, Marc, additional, Legarth, Rebecca, additional, Møller, Camilla Holten, additional, Skov, Robert Leo, additional, Valentiner-Branth, Palle, additional, Voldstedlund, Marianne, additional, Fischer, Thea K, additional, Simonsen, Lone, additional, Kirkby, Nikolai Søren, additional, Thomsen, Marianne Kragh, additional, Spiess, Katja, additional, Marving, Ellinor, additional, Larsen, Nicolai Balle, additional, Lillebaek, Troels, additional, Ullum, Henrik, additional, Mølbak, Kåre, additional, Krause, Tyra Grove, additional, Edslev, Sofie Marie, additional, Sieber, Raphael Niklaus, additional, Ingham, Anna Cäcilia, additional, Overvad, Maria, additional, Agermose Gram, Mie, additional, Kristensen Lomholt, Frederikke, additional, Hallundbæk, Louise, additional, Hjorth Espensen, Caroline, additional, Gubbels, Sophie, additional, Karakis, Marianne, additional, Lauenborg Møller, Karina, additional, Schytte Olsen, Stefan, additional, Harboe, Zitta Barrella, additional, Klint Johannesen, Caroline, additional, van Wijhe, Maarten, additional, Holler, Jon Gitz, additional, Dessau, Ram Benny Christian, additional, Barfred Friis, Martin, additional, Fuglsang-Damgaard, David, additional, Pinholt, Mette, additional, Vognbjerg Sydenham, Thomas, additional, Coia, John Eugenio, additional, Marmolin, Ea Sofie, additional, Fomsgaard, Anders, additional, Fonager, Jannik, additional, Rasmussen, Morten, additional, and Cohen, Arieh, additional

Published
2022
Full Text
View/download PDF

26. Molecular epidemiology of the SARS-CoV-2 variant Omicron BA.2 sub-lineage in Denmark, 29 November 2021 to 2 January 2022

Author

Fonager, Jannik, primary, Bennedbæk, Marc, additional, Bager, Peter, additional, Wohlfahrt, Jan, additional, Ellegaard, Kirsten Maren, additional, Ingham, Anna Cäcilia, additional, Edslev, Sofie Marie, additional, Stegger, Marc, additional, Sieber, Raphael Niklaus, additional, Lassauniere, Ria, additional, Fomsgaard, Anders, additional, Lillebaek, Troels, additional, Svarrer, Christina Wiid, additional, Møller, Frederik Trier, additional, Møller, Camilla Holten, additional, Legarth, Rebecca, additional, Sydenham, Thomas Vognbjerg, additional, Steinke, Kat, additional, Paulsen, Sarah Juel, additional, Castruita, José Alfredo Samaniego, additional, Schneider, Uffe Vest, additional, Schouw, Christian Højte, additional, Nielsen, Xiaohui Chen, additional, Overvad, Maria, additional, Nielsen, Rikke Thoft, additional, Marvig, Rasmus L, additional, Pedersen, Martin Schou, additional, Nielsen, Lene, additional, Nilsson, Line Lynge, additional, Bybjerg-Grauholm, Jonas, additional, Tarpgaard, Irene Harder, additional, Ebsen, Tine Snejbjerg, additional, Lam, Janni Uyen Hoa, additional, Gunalan, Vithiagaran, additional, and Rasmussen, Morten, additional

Published
2022
Full Text
View/download PDF

27. Post-acute symptoms, new onset diagnoses and health problems 6 to 12 months after SARS-CoV-2 infection: a nationwide questionnaire study in the adult Danish population

Author

Vedel Sørensen, Anna Irene, primary, Spiliopoulos, Lampros, additional, Bager, Peter, additional, Nielsen, Nete Munk, additional, Hansen, Jørgen Vinsløv, additional, Koch, Anders, additional, Meder, Inger Kristine, additional, Ethelberg, Steen, additional, and Hviid, Anders, additional

Published
2022
Full Text
View/download PDF

28. Self-Reported Adverse Events Following SARS-CoV-2 Vaccination: A Nationwide Questionnaire Study in the Adult Danish Population

Author

O'Regan, Elisabeth, primary, Svalgaard, Ingrid, additional, Sørensen, Anna Irene Vedel, additional, Spiliopoulos, Lampros, additional, Bager, Peter, additional, Nielsen, Nete, additional, Hansen, Jørgen Vinsløv, additional, Koch, Anders, additional, Meder, Inger Kristine, additional, Videbech, Poul, additional, Ethelberg, Steen, additional, and Hviid, Anders, additional

Published
2022
Full Text
View/download PDF

29. Observed Protection Against SARS-CoV-2 Reinfection Following a Primary Infection: A Danish Cohort Study Using Two Years of Nationwide PCR-Test Data

Author

Michlmayr, Daniela, primary, Hansen, Christian Holm, additional, Gubbels, Sophie Madeleine, additional, Valentiner-Branth, Palle, additional, Bager, Peter Michael, additional, Obel, Niels, additional, Drewes, Birgitte, additional, Holten Møller, Camilla, additional, Møller, Frederik Trier, additional, Legarth, Rebecca, additional, Mølbak, Kåre, additional, and Ethelberg, Steen, additional

Published
2022
Full Text
View/download PDF

30. Risk of Reinfection, Vaccine Protection, and Severity of Infection with the BA.5 Omicron Subvariant: A Danish Nation-Wide Population-Based Study

Author

Hansen, Christian Holm, primary, Friis, Nikolaj Ulrik, additional, Bager, Peter, additional, Stegger, Marc, additional, Fonager, Jannik, additional, Fomsgaard, Anders, additional, Gram, Mie Agermose, additional, Engbo Christiansen, Lasse, additional, Ethelberg, Steen, additional, Legarth, Rebecca, additional, Grove Krause, Tyra, additional, Ullum, Henrik, additional, and Valentiner-Branth, Palle, additional

Published
2022
Full Text
View/download PDF

31. Reduced Risk of Hospitalisation Associated With Infection With SARS-CoV-2 Omicron Relative to Delta: A Danish Cohort Study

Author

Bager, Peter, primary, Wohlfahrt, Jan, additional, Bhatt, Samir, additional, Edslev, Sofie Marie, additional, Sieber, Raphael Niklaus, additional, Ingham, Anna Cäcilia, additional, Stegger, Marc, additional, Legarth, Rebecca, additional, Holten Møller, Camilla, additional, Skov, Robert Leo, additional, Valentiner-Branth, Palle, additional, Overvad, Maria, additional, Gram, Mie Agermose, additional, Lomholt, Frederikke Kristensen, additional, Hallundbæk, Louise, additional, Espensen, Caroline Hjorth, additional, Gubbels, Sophie Madeleine, additional, Voldstedlund, Marianne, additional, Karakis, Marianne, additional, Møller, Karina Lauenborg, additional, Olsen, Stefan Schytte, additional, Fischer, Thea K., additional, Barrella Harboe, Zitta, additional, Johannesen, Caroline Klint, additional, Wiehe, Maarten Van, additional, Holler, Jon Gitz, additional, Simonsen, Lone, additional, Dessau, Ram Benny Christian, additional, Friis, Martin Barfred, additional, Fuglsang-Damgaard, David, additional, Pinholt, Mette, additional, Kirkby, Nikolai Søren, additional, Thomsen, Marianne Kragh, additional, Sydenham, Thomas Vognbjerg, additional, Coia, John Eugenio, additional, Marmolin, Ea Sofie, additional, Fomsgaard, Anders, additional, Fonager, Jannik, additional, Rasmussen, Morten, additional, Spiess, Katja, additional, Marving, Ellinor, additional, Cohen, Arieh, additional, Larsen, Nicolai Balle, additional, Lillebaek, Troels, additional, Ullum, Henrik, additional, Mølbak, Kåre, additional, and Grove Krause, Tyra, additional

Published
2022
Full Text
View/download PDF

35. Chronic hyperglycemia, hypercholesterolemia, and metabolic syndrome are associated with risk of tendon injury

Author

Skovgaard, Dorthe, primary, Siersma, Volkert D., additional, Klausen, Soren Bering, additional, Visnes, Håvard, additional, Haukenes, Inger, additional, Bang, Christine W., additional, Bager, Peter, additional, Grävare Silbernagel, Karin, additional, Gaida, Jamie, additional, Magnusson, Stig Peter, additional, Kjaer, Michael, additional, and Couppé, Christian, additional

Published
2021
Full Text
View/download PDF

37. Increased Risk of Hospitalisation Associated with Infection with SARS-CoV-2 Lineage B.1.1.7 in Denmark

Author

Bager, Peter, primary, Wohlfahrt, Jan, additional, Fonager, Jannik, additional, Albertsen, Mads, additional, Yssing Michaelsen, Thomas, additional, Holten Møller, Camilla, additional, Ethelberg, Steen, additional, Legarth, Rebecca, additional, Fischer Button, Mia Sara, additional, Gubbels, Sophie Madeleine, additional, Voldstedlund, Marianne, additional, Mølbak, Kåre, additional, Skov, Robert Leo, additional, Fomsgaard, Anders, additional, and Grove Krause, Tyra, additional

Published
2021
Full Text
View/download PDF

38. Tu1715 A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL ON EFFICACY AND SAFETY OF PROBIOTIC TREATMENT WITH TRICHURIS SUIS OVA IN PATIENTS WITH ULCERATIVE COLITIS

Author

Prosberg, Michelle V., Halkjær, Sofie I., Lo, Bobby Z., Köser, Christina B., Ilvemark, Johan F., Seidelin, Jakob B., Kristiansen, Malene F., Kort, Anja, Kallemose, Thomas, Nordgaard-Lassen, Inge, Bager, Peter, Bendtsen, Flemming, Kapel, Hanne, Kringel, Helene, Kapel, Christian, and Petersen, Andreas M.

Published
2023
Full Text
View/download PDF

44. Interaction between filaggrin mutations and neonatal cat exposure in atopic dermatitis

Author

Thyssen, Jacob P., primary, Ahluwalia, Tarunveer S., additional, Paternoster, Lavinia, additional, Ballardini, Natalia, additional, Bergström, Anna, additional, Melén, Erik, additional, Chawes, Bo L., additional, Stokholm, Jakob, additional, Hourihane, Jonathan O'B, additional, O'Sullivan, Donnchadh M., additional, Bager, Peter, additional, Melbye, Mads, additional, Bustamante, Mariona, additional, Torrent, Maties, additional, Esplugues, Ana, additional, Duijts, Liesbeth, additional, Hu, Chen, additional, Elbert, Niels J., additional, Pasmans, Suzanne G. M. A., additional, Nijsten, Tamar E. C., additional, von Berg, Andrea, additional, Standl, Marie, additional, Schikowski, Tamara, additional, Herberth, Gunda, additional, Heinrich, Joachim, additional, Lee, Young‐Ae, additional, Marenholz, Ingo, additional, Lau, Susanne, additional, Curtin, John A., additional, Simpson, Angela, additional, Custovic, Adnan, additional, Pennell, Craig E., additional, Wang, Carol A., additional, Holt, Patrick G., additional, Bisgaard, Hans, additional, and Bønnelykke, Klaus, additional

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results